100 mln doses of China Sinopharm's COVID-19 vaccines supplied globally

BEIJING: Two COVID-19 vaccines developed by subsidiaries of China National Pharmaceutical Group (Sinopharm) have hit a combined 100 million doses of supply around the world, a Sinopharm affiliate said late on Friday.

Over 80 million doses of the two vaccines were administered, China National Biotec Group Company (CNBG) said on social media. Sinopharm had said it could reach an annual capacity of 1 billion doses in 2021 and aims to expand capacity to 3 billion doses per year, without specifying the timeframe for the target.